207 related articles for article (PubMed ID: 35173147)
1. CHCHD2 and CHCHD10 regulate mitochondrial dynamics and integrated stress response.
Ruan Y; Hu J; Che Y; Liu Y; Luo Z; Cheng J; Han Q; He H; Zhou Q
Cell Death Dis; 2022 Feb; 13(2):156. PubMed ID: 35173147
[TBL] [Abstract][Full Text] [Related]
2. Twin CHCH Proteins, CHCHD2, and CHCHD10: Key Molecules of Parkinson's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.
Imai Y; Meng H; Shiba-Fukushima K; Hattori N
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791515
[TBL] [Abstract][Full Text] [Related]
3. Loss of CHCHD10-CHCHD2 complexes required for respiration underlies the pathogenicity of a CHCHD10 mutation in ALS.
Straub IR; Janer A; Weraarpachai W; Zinman L; Robertson J; Rogaeva E; Shoubridge EA
Hum Mol Genet; 2018 Jan; 27(1):178-189. PubMed ID: 29121267
[TBL] [Abstract][Full Text] [Related]
4. PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction.
Zhou W; Ma D; Sun AX; Tran HD; Ma DL; Singh BK; Zhou J; Zhang J; Wang D; Zhao Y; Yen PM; Goh E; Tan EK
Hum Mol Genet; 2019 Apr; 28(7):1100-1116. PubMed ID: 30496485
[TBL] [Abstract][Full Text] [Related]
5. Loss of mitochondrial Chchd10 or Chchd2 in zebrafish leads to an ALS-like phenotype and Complex I deficiency independent of the mitochondrial integrated stress response.
Petel Légaré V; Rampal CJ; Gurberg TJN; Aaltonen MJ; Janer A; Zinman L; Shoubridge EA; Armstrong GAB
Dev Neurobiol; 2023 Jan; 83(1-2):54-69. PubMed ID: 36799027
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions.
Burstein SR; Valsecchi F; Kawamata H; Bourens M; Zeng R; Zuberi A; Milner TA; Cloonan SM; Lutz C; Barrientos A; Manfredi G
Hum Mol Genet; 2018 Jan; 27(1):160-177. PubMed ID: 29112723
[TBL] [Abstract][Full Text] [Related]
7. CHCHD10 is involved in the development of Parkinson's disease caused by CHCHD2 loss-of-function mutation p.T61I.
Mao C; Wang H; Luo H; Zhang S; Xu H; Zhang S; Rosenblum J; Wang Z; Zhang Q; Tang M; Shepard MJ; Wang X; Wang Y; Zhuang Z; Shi C; Xu Y
Neurobiol Aging; 2019 Mar; 75():38-41. PubMed ID: 30530185
[TBL] [Abstract][Full Text] [Related]
8. CHCHD2 and CHCHD10-related neurodegeneration: molecular pathogenesis and the path to precision therapy.
Shammas MK; Huang TH; Narendra DP
Biochem Soc Trans; 2023 Apr; 51(2):797-809. PubMed ID: 37021679
[TBL] [Abstract][Full Text] [Related]
9. CHCHD2 accumulates in distressed mitochondria and facilitates oligomerization of CHCHD10.
Huang X; Wu BP; Nguyen D; Liu YT; Marani M; Hench J; Bénit P; Kozjak-Pavlovic V; Rustin P; Frank S; Narendra DP
Hum Mol Genet; 2018 Nov; 27(22):3881-3900. PubMed ID: 30084972
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial CHCHD-Containing Proteins: Physiologic Functions and Link with Neurodegenerative Diseases.
Zhou ZD; Saw WT; Tan EK
Mol Neurobiol; 2017 Sep; 54(7):5534-5546. PubMed ID: 27631878
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial CHCHD2 and CHCHD10: Roles in Neurological Diseases and Therapeutic Implications.
Zhou W; Ma D; Tan EK
Neuroscientist; 2020 Apr; 26(2):170-184. PubMed ID: 31526091
[No Abstract] [Full Text] [Related]
12. CHCHD10-regulated OPA1-mitofilin complex mediates TDP-43-induced mitochondrial phenotypes associated with frontotemporal dementia.
Liu T; Woo JA; Bukhari MZ; LePochat P; Chacko A; Selenica MB; Yan Y; Kotsiviras P; Buosi SC; Zhao X; Kang DE
FASEB J; 2020 Jun; 34(6):8493-8509. PubMed ID: 32369233
[TBL] [Abstract][Full Text] [Related]
13. Loss of CHCHD2 and CHCHD10 activates OMA1 peptidase to disrupt mitochondrial cristae phenocopying patient mutations.
Liu YT; Huang X; Nguyen D; Shammas MK; Wu BP; Dombi E; Springer DA; Poulton J; Sekine S; Narendra DP
Hum Mol Genet; 2020 Jun; 29(9):1547-1567. PubMed ID: 32338760
[TBL] [Abstract][Full Text] [Related]
14. The cellular stress proteins CHCHD10 and MNRR1 (CHCHD2): Partners in mitochondrial and nuclear function and dysfunction.
Purandare N; Somayajulu M; Hüttemann M; Grossman LI; Aras S
J Biol Chem; 2018 Apr; 293(17):6517-6529. PubMed ID: 29540477
[TBL] [Abstract][Full Text] [Related]
15. ALS/FTD mutant CHCHD10 mice reveal a tissue-specific toxic gain-of-function and mitochondrial stress response.
Anderson CJ; Bredvik K; Burstein SR; Davis C; Meadows SM; Dash J; Case L; Milner TA; Kawamata H; Zuberi A; Piersigilli A; Lutz C; Manfredi G
Acta Neuropathol; 2019 Jul; 138(1):103-121. PubMed ID: 30877432
[TBL] [Abstract][Full Text] [Related]
16. Mutation analysis of CHCHD2 and CHCHD10 in Italian patients with mitochondrial myopathy.
Rubino E; Zhang M; Mongini T; Boschi S; Vercelli L; Vacca A; Govone F; Gai A; Giordana MT; Grinberg M; Rogaeva E; Rainero I
Neurobiol Aging; 2018 Jun; 66():181.e1-181.e2. PubMed ID: 29519717
[TBL] [Abstract][Full Text] [Related]
17. ALS and Parkinson's disease genes CHCHD10 and CHCHD2 modify synaptic transcriptomes in human iPSC-derived motor neurons.
Harjuhaahto S; Rasila TS; Molchanova SM; Woldegebriel R; Kvist J; Konovalova S; Sainio MT; Pennonen J; Torregrosa-Muñumer R; Ibrahim H; Otonkoski T; Taira T; Ylikallio E; Tyynismaa H
Neurobiol Dis; 2020 Jul; 141():104940. PubMed ID: 32437855
[TBL] [Abstract][Full Text] [Related]
18. TDP-43 and PINK1 mediate CHCHD10
Baek M; Choe YJ; Bannwarth S; Kim J; Maitra S; Dorn GW; Taylor JP; Paquis-Flucklinger V; Kim NC
Nat Commun; 2021 Mar; 12(1):1924. PubMed ID: 33772006
[TBL] [Abstract][Full Text] [Related]
19. Pathological characterization of a novel mouse model expressing the PD-linked CHCHD2-T61I mutation.
Kee TR; Wehinger JL; Gonzalez PE; Nguyen E; McGill Percy KC; Khan SA; Chaput D; Wang X; Liu T; Kang DE; Woo JA
Hum Mol Genet; 2022 Nov; 31(23):3987-4005. PubMed ID: 35786718
[TBL] [Abstract][Full Text] [Related]
20. Neurodegeneration-associated mitochondrial proteins, CHCHD2 and CHCHD10-what distinguishes the two?
Ikeda A; Imai Y; Hattori N
Front Cell Dev Biol; 2022; 10():996061. PubMed ID: 36158221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
